Navigation Links
Preclinical Study Presented at AACR Annual Meeting Shows Broad Anti-Cancer Potential of Peregrine's anti-PS Vascular Targeting Antibodies
Date:4/14/2008

-Combination of a Bavituximab Equivalent and an Agent that Re-Activates the Tumor Suppressor P53 Inhibited Tumor Growth Synergistically in Preclinical

Breast Cancer Models-

SAN DIEGO and TUSTIN, Calif., April 14 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) announced today that a preclinical study being presented by an independent team of investigators at the 2008 Annual Meeting of the American Association for Cancer Research (AACR) further illustrates the broad anti-tumor potential of its anti-phosphatidylserine (anti-PS) vascular targeting antibodies. The study by Dr. Yayun Liang, Dr. Salman Hyder and colleagues at the University of Missouri describes promising anti-cancer activity observed when a mouse equivalent to the company's Phase II anti-PS antibody bavituximab was combined with an investigational agent that re-activates the tumor suppressor p53, which is turned off in many tumors. Bavituximab is a monoclonal antibody that is believed to work by selectively destroying the blood vessels supporting tumor growth and spread and by reversing the ability of tumors to suppress the body's natural immune response.

"This study highlights the broad anti-cancer potential of our anti-PS vascular targeting platform," said Steven W. King, president and CEO of Peregrine. "Numerous preclinical studies have shown the potential efficacy of our anti-PS antibodies in combination with both existing and novel therapies for the treatment of cancer. This new study further illustrates the potential versatility of our anti-PS antibodies in combination cancer therapy. We look forward to future clinical studies of bavituximab and other anti-PS antibodies in a broad range of anti-cancer regime
'/>"/>

SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
2. Lpath Demonstrates Preclinical Efficacy of Lpathomab(TM) and Initiates Humanization Process
3. Siemens Preclinical Imaging System Helps The Methodist Hospital in Houston Further Its Research Mission
4. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
5. NicOx and Ferrer Present Promising Clinical and Preclinical Results in Dermatology
6. Isis Reports Preclinical Data Supporting Liver Safety of ISIS 301012
7. Preclinical Data on Lead MEK Inhibitor, RDEA119, to be Presented at the 2007 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
8. KineMed Presents Preclinical Data for Investigational Agent Demonstrating Neurogenesis and Confirming Improvements in Behavioral Model
9. Tezampanel, TorreyPines Therapeutics Lead Compound, Reduced Muscle Spasticity and Rigidity in Preclinical Study Conducted at University of California, San Diego
10. Telik Announces Presentation of Preclinical Data on Dual Inhibitors of Aurora Kinases and VEGFR2
11. CorNova Preclinical Results of Valecor Platinum(TM) Coronary Stent Studies Presented at TCT 2007 Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...-FirstCall/--Vermillion,Inc.(VRML)(PinkSheets:VRML...ndDisclosureStatementtoday,November24,2009,withthe...e.AhearingtoconsiderapprovaloftheDisclosureStateme...ringontheconfirmationofthePlanscheduledforJanuary7...msinfull.ThePlanisexpected,ifapproved,toallowholde...
(Date:11/24/2009)....24/PRNewswire/-- EisaiInc.andPfizerIncannouncedt...ceptedforreviewEisai,sNewDrugApplication(NDA)foron...se)tabletsforthetreatmentofmoderatetosevereAlzheim...ns23mgofdonepezilHClinanextendedrelease,matrix-typ...aseofthedrug.TheNDAisbasedonahead-to-headclinicals...
(Date:11/24/2009)...ire-FirstCall/--ThoratecCorporation(Nasdaq: THOR )...pporttherapiestosave,supportandrestorefailingheart...lPiperJaffrayHealthCareConferenceonTuesday,Decembe...ieffinancialofficer,willprovideanupdateonthecompan...,PacificStandardTime). ,, Thepresentationwillbe...
Breaking Medicine Technology:Vermillion Files Plan of Reorganization 2Vermillion Files Plan of Reorganization 3FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 2FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 3IWillAgain com Launches Online Community for Athletes Overcoming Accident Illness or Injury 61623 1IWillAgain com Launches Online Community for Athletes Overcoming Accident Illness or Injury 61623 2Union Labor Life Selects Prescription Solutions To Provide Pharmacy Benefit Management Services 61619 1Union Labor Life Selects Prescription Solutions To Provide Pharmacy Benefit Management Services 61619 2Union Labor Life Selects Prescription Solutions To Provide Pharmacy Benefit Management Services 61619 3Knome Launches First Platform Agnostic Human Genome Sequencing and Analysis Service for Researchers 14898 1Knome Launches First Platform Agnostic Human Genome Sequencing and Analysis Service for Researchers 14898 2Knome Launches First Platform Agnostic Human Genome Sequencing and Analysis Service for Researchers 14898 3
... Findings Show Cystic Fibrosis Patients Cough More... -, SOUTH PLAINFIELD, N.J., May 21 PTC Th...ggesting that the quantification of cough,frequenc...e in cystic,fibrosis (CF). Cough is one of the mos...s in CF. According to data presented today at the,...
... Data Presented at American Urological Association... 21 Researchers,from Dendreon Corporation (Nasdaq...rating the potential of D-3263, Dendreon,s orally ...(a transmembrane cation channel protein also,known... (BPH)., The abstract (#2041), "Preclinical Valid...
Other Medicine Technology:PTC Therapeutics Announces Data Supporting Cough Frequency as a New Outcome Measure in Evaluating Treatments for Cystic Fibrosis 2PTC Therapeutics Announces Data Supporting Cough Frequency as a New Outcome Measure in Evaluating Treatments for Cystic Fibrosis 3PTC Therapeutics Announces Data Supporting Cough Frequency as a New Outcome Measure in Evaluating Treatments for Cystic Fibrosis 4Dendreon Presents Preclinical Data Demonstrating Activity of Trp-p8 agonist, D-3263, in Benign Prostatic Hyperplasia 2Dendreon Presents Preclinical Data Demonstrating Activity of Trp-p8 agonist, D-3263, in Benign Prostatic Hyperplasia 3Dendreon Presents Preclinical Data Demonstrating Activity of Trp-p8 agonist, D-3263, in Benign Prostatic Hyperplasia 4
(Date:11/25/2009)... Evaluation and treatment cli... Woodstock (Vocus) November 25, 2009 -- Cen...sal vaccines and H1N1 vaccine shots at four Centeg...other shipment of vaccine has arrived. The clinics...ake and McHenry and will be open as follows: , ...
(Date:11/25/2009)...ivors often plagued by neurological symptoms, stud...ay News) -- Neurological side effects are among th...of testicular cancer who were treated with cisplat... The study included 1,409 Norwegian men treated fo...94 who took part in a follow-up survey conducted f...
(Date:11/25/2009)..., NEWYORK,Nov.25/PRNewswire/-- MISSIONSkincare &...millionforSt.Jude.AspartofGNC,sannualSt.Jude Thank...MISSIONSkincare,s new SUPER-C(TM)LipBalm willbed...portunitytomakea$1,$5or$10donationatcheckoutatoneo...aisemorethan$1millionforSt.Judeduringtheir2009 Tha...
(Date:11/25/2009)..., LittleImprovementShownforthe4thStraightYear ... Today,LungCancerAlliance-Georgia(LCA-GA)issuedth...ssessmentofprogressbeingmadeagainstthislethaldisea...Alliance(LCA),theonlynationalorganizationdedicated...ingwithoratriskforlungcancer. ,, (Logo: http://...
(Date:11/25/2009)...drug used to treat colorectal cancer also can reve...ed first-line therapy for the disease, researchers...is week. , Mntrier,s disease causes thickening of... and vomiting, as well as anemia and swelling in t...re at increased risk for gastric cancer. Previousl...
Breaking Medicine News(10 mins):Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4Health News:MISSION Skincare(R) Supports GNC's Efforts To Raise Money for St. Jude Children's Research Hospital(R) 2Health News:Lung Cancer Alliance-Georgia Issues 4th Annual State-Specific Report Card on Lung Cancer 2Health News:Vanderbilt scientists report first effective medical therapy for rare stomach disorder 2
...atic New Study Presented in Congressional Briefing...which Congress prepared to vote on the Obama admin...s package, the nation,s largest organization of re... the nation,s healthcare crisis overnight. , , In...
... the National Family Planning and Reproductive Hea... to recent reports federal funding for family plan...essional Budget Office (CBO) the Family Planning M... that have flooded America,s airwaves and papers o...
...A MONICA, Calif., Jan. 28 Consumer Watchdog warne... nursing home worker unions in California will lea...s the agreements negotiated by SEIU tend to put th...of caregivers to blow the whistle on quality of ca...
...avioral weight-loss programs can be an effective w... overweight or obese, according to a study led by ...rancisco. , Volunteer participants in the Program...continence episodes, according to the study. Findi...
... Behavioral weight-loss progra...tinence in women who are overweight or obese, acco...ity of California, San Francisco. , ...ght or obese, according to a study led by research...
...state-of-the-art facility, located just outside of... environment for the professional development and ..., GLENDALE, Ariz., Jan. 28 Today, Grifols SA (Gri...e, Arizona. The Academy is an 8,500 square foot f...
Other Medicine News:Health News:Nurses to Congress: Expanding Medicare Could Reverse Job Losses, and Repair Our Broken Healthcare System and Safety Net 2Health News:Nurses to Congress: Expanding Medicare Could Reverse Job Losses, and Repair Our Broken Healthcare System and Safety Net 3Health News:Get the Facts the House Republicans Don't Want You to Have 2Health News:Weight loss reduces incontinence in obese women, UCSF study shows 2Health News:Weight Loss Reduces Incontinence In Obese Women, UCSF Study Shows 2Health News:Weight Loss Reduces Incontinence In Obese Women, UCSF Study Shows 3Health News:Grifols Inaugurates the GRIFOLS ACADEMY OF PLASMAPHERESIS in Glendale, Arizona 2Health News:Grifols Inaugurates the GRIFOLS ACADEMY OF PLASMAPHERESIS in Glendale, Arizona 3
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
Medicine Products: